SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Cipla has reported results for the fourth quarter and year ended March 31, 2018. 

The company has reported over 8-fold jump in its net profit at Rs 224.81 crore for the quarter ended March 31, 2018 as compared to Rs 25.86 crore for the same quarter in the previous year. Total income of the company increased by 2.65% at Rs 2,788.22 crore for quarter under review as compared to Rs 2,716.36 crore for the quarter ended March 31, 2017.

On consolidated basis, the company has reported net profit of Rs 178.61 crore for the quarter ended March 31, 2018 as compared to net loss of Rs 61.79 crore for the corresponding quarter in the FY17. Total consolidated income of the company rose 3.69% at Rs 3,737.98 crore for quarter under review as compared to Rs 3,604.79 crore for the same quarter ended previous year.

For the year ended March 31, 2018, the company has posted a rise of 50.63% in its net profit at Rs 1,468.52 crore as compared to Rs 974.94 crore for the previous year. Total income of company increased 6.08% at Rs 11,779.69 crore for year under review as compared to Rs 11,104.43 crore for the year ended March 31, 2017.

For the year ended March 31, 2018, on the consolidated basis, the company has posted rise of 40.16% in its net profit at Rs 1,410.53 crore as compared to Rs 1,006.39 crore for the previous year. Total consolidated income of company increased by 4.83% at Rs 15,576.90 crore for year under review as compared to Rs 14,858.93 crore for the year ended March 31, 2017.

Cipla Share Price

1438.75 -2.95 (-0.20%)
10-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1935.25
Dr. Reddys Labs. 1245.50
Cipla 1438.75
Zydus Lifesciences 1150.50
Lupin 2496.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: